CircCFL1 Promotes TNBC Stemness and Immunoescape via Deacetylation‐Mediated c‐Myc Deubiquitylation to Facilitate Mutant TP53 Transcription
Advanced Science · 2024
DOI: 10.1002/advs.202404628 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Zekun Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, P. R. China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program, Special Foundation for Taishan Scholars, Foundation from Clinical Research Center of Shandong University.
Abstract (Originalsprache)
Triple‐negative breast cancer (TNBC) is the most malignant subtype of breast cancer. TP53, which has a mutation rate of ≈70%–80% in TNBC patients, plays oncogenic roles when mutated. However, whether circRNAs can exert their effects on TNBC through regulating mutant TP53 has not been well evaluated. In this study, circCFL1, which is highly expressed in TNBC cells and tissues and has prognostic potential is identified. Functionally, circCFL1 promoted the proliferation, metastasis and stemness of TNBC cells. Mechanistically, circCFL1 acted as a scaffold to enhance the interaction between HDAC1 and c‐Myc, further promoting the stability of c‐Myc via deacetylation‐mediated inhibition of K48‐linked ubiquitylation. Stably expressed c‐Myc further enhanced the expression of mutp53 in TNBC cells with TP53 mutations by directly binding to the promoter of TP53, which promoted the stemness of TNBC cells via activation of the p‐AKT/WIP/YAP/TAZ pathway. Moreover, circCFL1 can facilitate the immune escape of TNBC cells by promoting the expression of PD‐L1 and suppressing the antitumor immunity of CD8 + T cells. In conclusion, the results revealed that circCFL1 plays an oncogenic role by promoting the HDAC1/c‐Myc/mutp53 axis, which can serve as a potential diagnostic biomarker and therapeutic target for TNBC patients with TP53 mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, P. R. China.
- School of Basic Medicine, Jining Medical College, Jining, Shandong, 272067, P. R. China.
- Pathology Tissue Bank, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, P. R. China.
- Research Institute of Breast Cancer, Shandong University, Jinan, Shandong, 250012, P. R. China.
ORCID-Profile: Zekun Wang, Qifeng Yang
Förderung
- National Key Research and Development Program
- Special Foundation for Taishan Scholars
- Foundation from Clinical Research Center of Shandong University
- Qilu Hospital Clinical New Technology Developing Foundation
- China Postdoctoral Science Foundation
- Natural Science Foundation of Shandong Province
- Mount Taishan Scholar Young Expert
- National Key Research and Development Program of China
Zitieren
APA
Wang, Z., Li, Y., Yang, J., Sun, Y., He, Y., Wang, Y., Liang, Y., Chen, X., Chen, T., Han, D., Zhang, N., Chen, B., Zhao, W., Wang, L., Luo, D., & Yang, Q. (2024). CircCFL1 Promotes TNBC Stemness and Immunoescape via Deacetylation‐Mediated c‐Myc Deubiquitylation to Facilitate Mutant TP53 Transcription. Advanced Science. https://doi.org/10.1002/advs.202404628
Vancouver
Wang Z, Li Y, Yang J, Sun Y, He Y, Wang Y, et al. CircCFL1 Promotes TNBC Stemness and Immunoescape via Deacetylation‐Mediated c‐Myc Deubiquitylation to Facilitate Mutant TP53 Transcription. Advanced Science. 2024. doi:10.1002/advs.202404628
BibTeX
@article{Wang2024,
author = {Wang, Zekun and Li, Yaming and Yang, Jingwen and Sun, Yuhan and He, Yinqiao and Wang, Yuping and Liang, Yiran and Chen, Xi and Chen, Tong and Han, Dianwen and Zhang, Ning and Chen, Bing and Zhao, Wenjing and Wang, Lijuan and Luo, Dan and Yang, Qifeng},
title = {CircCFL1 Promotes TNBC Stemness and Immunoescape via Deacetylation‐Mediated c‐Myc Deubiquitylation to Facilitate Mutant TP53 Transcription},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202404628}
}
EUVIMED